Red Barrels has unleashed Season 4.0 of The Outlast Trials, titled Project Diarchy, a massive free update that is available on Xbox, PlayStation, and PC.

QBiotics CEO, Stephen Doyle, reflecting on Soft Tissue Sarcoma data Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 ...

BRISBANE, Australia, June 25, 2025 /PRNewswire/ -- Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 (10 evaluable ...

BRISBANE, Australia, June 25, 2025 /PRNewswire/ -- Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 (10 evaluable) ...

Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 (10 evaluable) patients with advanced Soft Tissue Sarcoma (STS). An ...

Results from the Phase 1b clinical trial demonstrated a significant 40% objective response rate for the combination of onvansertib and paclitaxel in metastatic triple-negative breast cancer (mTNBC).

Xilio Therapeutics reports 26% response rate for vilastobart and atezolizumab in metastatic MSS CRC patients, with favorable safety profile.